ImpediMed (IPD) News Today → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free IPD Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineImpediMed's (ASX:IPD) investors will be pleased with their notable 72% return over the last yearfinance.yahoo.com - March 14 at 1:15 AMSkin in the game: Which ASX director is betting on a lithium recovery?msn.com - March 11 at 7:41 AMImpedimed Stock (OTC:IPDQF) Dividends: History, Yield and Datesbenzinga.com - February 26 at 10:02 PMHow the experts are investing in healthcare-related AI and biotechmsn.com - February 20 at 9:11 PMScoPo’s Powerplays: ASX health stocks tumble as CSL bleeds after Phase III trial misses endpointmsn.com - February 16 at 12:02 AMImpedimed Ltd IPDmorningstar.com - February 3 at 3:11 PMMarket Highlights: Wall Street sentiment remains high, 9 most innovative firms, and 5 small caps to watch todaymsn.com - November 19 at 10:02 PM2 ASX All Ords shares tumbling following leadership shakeupsfool.com.au - November 19 at 10:02 PMScoPo’s Powerplays: Who fancies 22 minutes of exercise? And ASX health stocks are up (finally)msn.com - November 3 at 5:28 AMImpediMed Limitedafr.com - October 21 at 2:16 PMInvesting in ImpediMed (ASX:IPD) a year ago would have delivered you a 146% gainfinance.yahoo.com - October 6 at 1:52 AMAnalysts Expect Breakeven For ImpediMed Limited (ASX:IPD) Before Longfinance.yahoo.com - September 1 at 5:52 PMThe IPD Group Limited (ASX:IPG) Annual Results Are Out And Analysts Have Published New Forecastsfinance.yahoo.com - August 29 at 5:29 PMHere's Why We're Watching ImpediMed's (ASX:IPD) Cash Burn Situationfinance.yahoo.com - July 17 at 10:24 AMIPD.AX - ImpediMed Limitedfinance.yahoo.com - July 13 at 3:02 PMIPD.XA - ImpediMed Limitedau.finance.yahoo.com - July 12 at 1:53 PMScoPo’s (actually Wilkie’s) Powerplays: Inoviq soars on clinical data for breast cancer testmsn.com - June 30 at 1:29 AMScoPo’s Powerplays: ASX health stocks fall as investors fail to reward good newsmsn.com - May 26 at 1:35 AMWILSONS Maintains ImpediMed (ASX:IPD) Overweight Recommendationmsn.com - April 22 at 12:28 AMScoPo’s (actually Iain’s) Powerplays: ASX health stocks fall, Neuren’s DAYBUE drug officially rolling out in USmsn.com - April 21 at 1:28 AMImpediMed (ASX:IPD) shareholders have earned a 40% CAGR over the last three yearsfinance.yahoo.com - April 7 at 8:48 PMScoPo’s Powerplays: ASX health stocks rise, ImpediMed surges 99% on NCCN guidelines updatemsn.com - March 31 at 10:32 AMGuess which ASX biotech share just rocketed 86% on ‘a major validating moment’msn.com - March 27 at 9:59 AMASX Small Caps Lunch Wrap: Who else is having trouble believing their eyes this morning?msn.com - March 26 at 11:55 PMTop 10 at 10: Cancer fighters, new lithium leaders, and a lucrative takeover offermsn.com - March 26 at 11:55 PMASX Health Stocks: ImpediMed pops over 60pc after BIS technology named in new US guidelinesmsn.com - March 26 at 11:55 PMImpediMed First Half 2023 Earnings: AU$0.01 loss per share (vs AU$0.006 loss in 1H 2022)finance.yahoo.com - February 25 at 10:25 PMWill ImpediMed (ASX:IPD) Spend Its Cash Wisely?finance.yahoo.com - February 6 at 11:09 PMNew Data Presented at the 2022 San Antonio Breast Cancer Symposium Shows Early Detection using L-Dex and Intervention Improves Lymphedema Progression-Free Survivalfinance.yahoo.com - December 15 at 9:38 AMImpediMed Extends Contract for AstraZeneca for Use of the SOZO Digital Health Platform in Clinical Trial of Patients with Chronic Kidney Diseasefinance.yahoo.com - November 16 at 4:21 PMImpediMed Reaches Milestone of 500,000 Patient Tests Performed with the SOZO Digital Health Platformfinance.yahoo.com - November 2 at 4:28 PMCurrent Data Support Early Detection and Intervention to Reduce Rates of Breast Cancer-Related Lymphedemafinance.yahoo.com - October 26 at 9:15 AMNew Data Confirms Early Detection and Intervention of Lymphedema Improves Quality of Life for Breast Cancer Patients Who Avoid Chronic Lymphedemafinance.yahoo.com - October 20 at 9:56 AMImpediMed Expands Use of SOZO in Leading Cancer Centers Focused on Reducing the Impact of Lymphedema after Breast Cancerfinance.yahoo.com - October 11 at 10:09 AMWhen Will ImpediMed Limited (ASX:IPD) Turn A Profit?finance.yahoo.com - October 10 at 8:00 PMImpediMed Announces U.S. Launch of Lymphedema Prevention Program with GenesisCare a Global Organization Dedicated to Care of Cancer Patientsfinance.yahoo.com - October 4 at 12:40 PMImpediMed Announces Two Posters at Heart Failure Society of America Annual Scientific Meeting That Demonstrate Utility of SOZO® Digital Health Platform for Heart Failure Patientsfinance.yahoo.com - September 30 at 10:46 AMIPD.AX - Impedimed Limited | Stock Price & Latest News | Reutersreuters.com - September 23 at 10:53 PMWe're Not Very Worried About ImpediMed's (ASX:IPD) Cash Burn Ratefinance.yahoo.com - August 30 at 10:55 PMNew Data Evaluating ImpediMed’s SOZO® in Heart Failure Patients to be Presented at Heart Failure Society of America Annual Scientific Meeting 2022apnews.com - July 17 at 7:48 AMNew Data Evaluating ImpediMed's SOZO® in Heart Failure Patients to be Presented at Heart Failure Society of America Annual Scientific Meeting 2022finance.yahoo.com - July 15 at 1:39 PMASX Health Stocks: ImpediMed extends SOZO contract with global pharma AstraZenecamsn.com - March 18 at 1:55 AMNew Bone Data Showing Strong Correlation between ImpediMed's SOZO and DXA in Cancer Patients Presented at 39th Annual Miami Breast Cancer Conferencefinance.yahoo.com - March 7 at 9:19 AMWe Think ImpediMed (ASX:IPD) Can Afford To Drive Business Growthfinance.yahoo.com - February 23 at 5:26 PMNew Data Evaluating ImpediMed's SOZO® Digital Health Platform to Assess Bone in Cancer Patients to be Presented at 39th Annual Miami Breast Cancer Conferencefinance.yahoo.com - February 15 at 9:55 AMNew Data Show Statistically Significant Reduction in Chronic Cancer-Related Lymphedema with Early Detection Using ImpediMed's L-Dex® Technology and Interventionfinance.yahoo.com - February 1 at 11:11 AMImpediMed (ASX:IPD) investors are sitting on a loss of 80% if they invested five years agofinance.yahoo.com - January 10 at 12:23 AMAsk SCORE: How can I build a strong brand for my business?news.yahoo.com - November 28 at 6:05 PMImpediMed Limited's (ASX:IPD) Intrinsic Value Is Potentially 32% Above Its Share Pricefinance.yahoo.com - November 24 at 11:13 PMImpedimed (ASX:IPD) share price dips following capital raising updatemsn.com - October 27 at 12:19 AM Get ImpediMed News Delivered to You Automatically Sign up to receive the latest news and ratings for IPD and its competitors with MarketBeat's FREE daily newsletter. Email Address The Next Nvidia? (Ad)The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about. Go here now for this breaking story. IPD Media Mentions By Week IPD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPD News Sentiment▼0.000.49▲Average Medical News Sentiment IPD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPD Articles This Week▼00▲IPD Articles Average Week Get ImpediMed News Delivered to You Automatically Sign up to receive the latest news and ratings for IPD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cell MedX News Cochlear News Evome Medical Technologies News GN Store Nord A/S News Hamilton Thorne News Heart Test Laboratories News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:IPD) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressThe “Perfect Storm” for GoldGold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe Next Nvidia?InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImpediMed Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.